Summit Therapeutics (SUMM)

 

Latest News

Summit Therapeutics plc : Holding(s) in Company

Summit Therapeutics plc: Holding(s) in Company TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: SUMMIT THERAPEUTICS PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if ap...

Summit Therapeutics plc : Holding(s) in Company

Summit Therapeutics plc: Holding(s) in Company TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Summit Therapeutics PLC Sedol BN40HZ0 1b. Please indicate if the issuer is a non-UK issuer (please mark with an...

Summit Therapeutics Announces Closing of its ADS Public Offering Raising USD20.1M Before Expenses

Summit Therapeutics Announces Closing of its ADS Public Offering Raising USD20.1M Before Expenses NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Sum...

Summit Therapeutics Announces Exercise of Underwriters' Over-Allotment Option

Summit Therapeutics Announces Exercise of Underwriters' Over-Allotment Option NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Summit Therapeutics plc...

All News

DateHeadlineSource
21-09-17Summit Therapeutics plc : Holding(s) in CompanyRNS
20-09-17Summit Therapeutics plc : Holding(s) in CompanyRNS
18-09-17Summit Therapeutics Announces Closing of its ADS Public Offering Raising USD20.1M Before ExpensesRNS
15-09-17Summit Therapeutics Announces Exercise of Underwriters' Over-Allotment OptionRNS
14-09-17Summit Announces Underwritten Public Offering of 1,459,000 ADSs to Raise USD17.5 Million Before ExpensesRNS
11-09-17Summit awarded Barda contract worth up to $62mStockMarketWire
11-09-17Summit Therapeutics Awarded BARDA Contract Worth Up To $62M To Support Development of Ridinilazole for CDIRNS
05-09-17Summit announces positive ridinilazole trial resultsStockMarketWire
05-09-17Summit Therapeutics plc : Positive Top-line Phase 2 ResultsRNS
31-08-17Summit Therapeutics plc : Half-yearly reportRNS
25-08-17Summit Therapeutics plc : Notice of ResultsRNS
03-08-17Summit Therapeutics to Present at the Canaccord Genuity Growth ConferenceRNS
31-07-17Summit Therapeutics plc : Total voting rightsRNS
19-07-17Summit Therapeutics plc : Grant of Share Options and Restricted Stock UnitsRNS
18-07-17Summit Therapeutics plc : Result of AGMRNS
28-06-17Summit Therapeutics plc : Exercise of Share OptionsRNS
28-06-17Summit Therapeutics plc : Grant of Share OptionsRNS
22-06-17Summit Presents Data from Phase 1 Clinical Programme of Ezutromid at the EPNS CongressRNS
16-06-17Four AIM shares for a post-election worldInteractive Investor
15-06-17Summit Therapeutics to Participate in JMP Securities Life Sciences ConferenceRNS
14-06-17Summit losses fallStockMarketWire
14-06-17Summit Therapeutics plc : 1st Quarter ResultsRNS
13-06-17Summit confirms date of Q1 results announcementStockMarketWire
13-06-17Summit Therapeutics plc : Notice of ResultsRNS
05-06-17Summit highlights benefits of ridinilazole at ASM MicrobeStockMarketWire
05-06-17Summit Presents Positive New Preclinical Data on Novel CDI Antibiotic Ridinilazole at ASM Microbe 2017RNS
23-05-17Summit Announces Key Appointments to Strengthen Research & Development TeamRNS
15-05-17Summit completes PhaseOut DMD enrolmentStockMarketWire
15-05-17Summit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMDRNS
02-05-17Summit Therapeutics plc: Phase 2 CoDIFy Trial Results Published in Lancet Infectious DiseasesRNS
25-04-17Summit Therapeutics plc : Notice of AGMRNS
12-04-17Summit Therapeutics plc : Grant of Share OptionsRNS
10-04-17Summit Therapeutics plc : Exercise of OptionsRNS
31-03-17Summit Therapeutics File US Annual Report on Form 20-FRNS
30-03-17Summit changes registered officeStockMarketWire
30-03-17Summit Therapeutics plc : Change of Registered OfficeRNS
30-03-17Summit Therapeutics to Present at the Needham Healthcare ConferenceRNS
29-03-17Summit Therapeutics Reports 4th Quarter and Year End Financial Results and Operational ProgressRNS
27-03-17Summit schedules FY resultsStockMarketWire
27-03-17Summit to extend PhaseOut DMD clinical trialStockMarketWire

RSS feeds

  • Editorial news feed for LSE:SUMM Editorial
  • Regulatory news feed for LSE:SUMM Regulatory